ClinicalTrials.gg
CompletedNCT04612387Updated Apr 5, 2022

Online Wellness Intervention in Medical Students

An interventional study of Mind-body therapy in Stress, Psychological, Mind Body Therapy and Wellbeing, sponsored by University of Alberta. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-05.

Sponsored by University of Alberta · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Medical students are at high risk of stress. This project will test how well a 12-week stress reduction program works to reduce stress, anxiety and depression and improve well-being. The program is delivered online and each week is made of an introduction video, 7-8 minutes of yoga, 5-7 minutes of meditation and nutrition tips. At the beginning and the end of the 12-week research study, we will be using surveys to ask students about their stress, anxiety, depression, sense of control over their own life, quality of life, and pain levels. After the program, the research team will conduct interviews with the medical student to allow them to share their other feedback about the program. The researchers will also send surveys to the medical students one month after the program ends to asses their continued satisfaction with and adherence to the program.

02

Conditions studied

  • Stress, Psychological
  • Mind Body Therapy
  • Wellbeing

Browse trials for

03

In context

Stress, Psychological

806 studies on the registry are indexed under Stress, Psychological; 131 are open to participants now.

This study's enrollment of 65 is below the median of 84 across 651 interventional studies indexed under Stress, Psychological.

Browse Stress, Psychological studies →

Lead sponsor

University of Alberta is the lead sponsor of 819 studies on the registry; 166 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Medical students in any year of medical school

Exclusion criteria

Exclusion Criteria:

  • Hospital Anxiety and Depression Scale (HADS) Depression score >10
  • Active psychosis
  • Post-traumatic stress disorder or frequent suicidal ideation
  • Major medical co-morbidity
  • Inability to provide written informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Mind-body Intervention arm

    Online yoga, meditation and nutrition tips.

    Behavioral: Mind-body therapy

Interventions

  • BehavioralMind-body therapy

    Online yoga, meditation and nutrition tips.

06

What researchers measure

Primary outcomes

  1. Perceived Stress Scale

    The degree to which situations in one's life are appraised as stressful will be assessed using the Perceived Stress Scale. The minimum score is 0, the maximum score is 40, and higher scores indicate a worse outcome.

    Time frame: 12 weeks

Secondary outcomes

  1. Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) will be used to measure depression. The minimum score is 0, the maximum is 27, and higher scores indicate a worse outcome.

    Time frame: 12 weeks

  2. Psychological Wellbeing Scale

    The Psychological Wellbeing Scale will be sued to measure well being. Higher scores mean higher levels of psychological well-being

    Time frame: 12 weeks

  3. Five Facet Mindfulness Questionnaire

    Mindfulness will be assessed using the Five Facet Mindfulness Questionnaire.

    Time frame: 12 weeks

  4. Hospital Anxiety and Depression Scale (HADS)

    Depression and anxiety will be measured on the Hospital Anxiety and Depression Scale. The minimum value is 0, the maximum is 21, and higher scores mean a worse outcome.

    Time frame: 12 weeks

07

Study locations

1 site
  • University of Alberta
    Edmonton, Alberta T6G 2C8, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04612387
Responsible party
Sponsor
First posted
Nov 3, 2020
Start date
Oct 25, 2020
Primary completion
Jan 31, 2021
Completion
Apr 30, 2021
Last update
Apr 5, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion